The ACT Network, Built by CTSAs, for CTSAs
The ACT (an acronym for Accrual to Clinical Trials) Network is an IT platform that allows investigators to query de-identified EHR data across the CTSA consortium under a data governance agreement that allows researchers to explore and validate feasibility
for clinical studies by themselves from their desktop, in minutes. ACT helps clinical investigators conduct cohort discovery before a trial starts, to establish feasibility of a clinical protocol for grant applications, IRB submission, etc. ACT also helps
investigators identify additional sites for a clinical trial. By allowing investigators to thoroughly explore patient cohorts and potential sites before finalizing their clinical protocols, ACT increases the odds of successfully completing clinical trial
recruitment. ACT was developed collaboratively by members of NCATS’ Clinical and Translational Science Award (CTSA) consortium, with funding from the NIH National Center for Advancing Translational Sciences.
Using ACT, clinical investigators can:
- Conduct early-stage cohort discovery and explore patient populations
- Test and refine study eligibility criteria in real-time
- Identify potential partner sites for multi-site studies
- Demonstrate study feasibility in funding proposals and IRB submissions
Who can use it? (Open to anyone at UTMB.)
How do I get access? You can submit a request for services at https://utmb.us/3ve.
Find your Trusted Requestor here!
To learn more or use ACT, visit the ACT Network.
Get the ACT Network flyer here!
Contact: CTSA@utmb.edu or x72872 (CTSA)